EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Diagnostic Test Accuracy and Semi-Quantitative Metrics of 18F-FDG PET in Assessing Treatment Response in Skull Base Osteomyelitis and Necrotising Otitis Externa: A Systematic Review and Meta-Analysis

Mark Laidlaw iD, Maya Reid, Sukanya Rajiv, Jean-Marc Gerard iD

Tomography · 02.03.2026 · 12 (3) · 32

DOI: 10.3390/tomography12030032 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Tomography, online erschienen am 02.03.2026. Verfasst von Mark Laidlaw und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Royal Victorian Eye and Ear Hospital, Melbourne, VIC 3002, Australia. Hauptthemen laut MEDLINE: Osteomyelitis, Otitis Externa, Fluorodeoxyglucose F18, Skull Base. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Skull base osteomyelitis and necrotising otitis externa require prolonged antibiotic therapy, yet determining optimal treatment cessation timing remains challenging. Conventional imaging modalities demonstrate persistent abnormalities beyond infection resolution, confounding treatment decisions. This systematic review evaluated the diagnostic test accuracy of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) for treatment response monitoring in skull base osteomyelitis and necrotising otitis externa.

Methods

We conducted a systematic review following PRISMA-DTA guidelines, searching MEDLINE, Embase, CENTRAL, CINAHL, Scopus, and Web of Science from inception to November 2025. Studies evaluating 18F-FDG PET diagnostic accuracy for treatment response assessment in confirmed skull base osteomyelitis or necrotising otitis externa were included. Two reviewers independently screened studies, extracted data, and assessed risk of bias using QUADAS-2. Bivariate random-effects meta-analysis was performed using MetaBayesDTA to obtain pooled sensitivity and specificity.

Results

Eight studies comprising 154 lesions contributed to the primary analysis. Pooled sensitivity was 95.2% (95% credible interval 85.6–99.0%) and pooled specificity was 89.1% (95% credible interval 70.7–96.7%). The positive likelihood ratio was 8.7 (95% credible interval 3.2–28.4) and negative likelihood ratio was 0.05 (95% credible interval 0.01–0.17), with a diagnostic odds ratio of 172.0. Seven studies evaluating detection rate at initial presentation yielded a pooled rate of 96.1% (95% confidence interval 91.3–98.3%). SUVmax was the most frequently used metabolic parameter.

Conclusions

18F-FDG PET, specifically using SUVmax, demonstrates high sensitivity and good specificity for treatment response monitoring, with excellent capacity to rule out persistent infection. However, evidence quality is limited by retrospective designs and substantial heterogeneity. Prospective studies with standardised thresholds are needed to validate clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisOtitis ExternaFluorodeoxyglucose F18Skull BasePositron-Emission TomographyHumansRadiopharmaceuticalsNecrosisAnti-Bacterial AgentsSensitivity and SpecificityTreatment Outcome

Stichwörter der Autor:innen

diagnostic test accuracyfluorodeoxyglucose F18malignant otitis externameta-analysisnecrotising otitis externapositron emission tomographyskull base osteomyelitissystematic reviewtreatment monitoring

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Otolaryngology, Royal Victorian Eye and Ear Hospital, Melbourne, VIC 3002, Australia.
  • Department of Otolaryngology, Head and Neck Surgery, Canberra Health Service, Canberra, ACT 2605, Australia.
  • Victorian Cochlear Implant Program, Royal Victorian Eye and Ear Hospital, Melbourne, VIC 3002, Australia.
  • Department of Otolaryngology, University of Melbourne, Melbourne, VIC 3010, Australia.

ORCID-Profile: Mark Laidlaw, Jean-Marc Gerard

Zitieren

APA

Laidlaw, M., Reid, M., Rajiv, S., & Gerard, J. M. (2026). Diagnostic Test Accuracy and Semi-Quantitative Metrics of 18F-FDG PET in Assessing Treatment Response in Skull Base Osteomyelitis and Necrotising Otitis Externa: A Systematic Review and Meta-Analysis. Tomography, 12(3), 32. https://doi.org/10.3390/tomography12030032

Vancouver

Laidlaw M, Reid M, Rajiv S, Gerard JM. Diagnostic Test Accuracy and Semi-Quantitative Metrics of 18F-FDG PET in Assessing Treatment Response in Skull Base Osteomyelitis and Necrotising Otitis Externa: A Systematic Review and Meta-Analysis. Tomography. 2026;12(3):32. doi:10.3390/tomography12030032

BibTeX
@article{Laidlaw2026,
  author = {Laidlaw, Mark and Reid, Maya and Rajiv, Sukanya and Gerard, Jean-Marc},
  title = {Diagnostic Test Accuracy and Semi-Quantitative Metrics of 18F-FDG PET in Assessing Treatment Response in Skull Base Osteomyelitis and Necrotising Otitis Externa: A Systematic Review and Meta-Analysis},
  journal = {Tomography},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {32},
  doi = {10.3390/tomography12030032}
}
Kostenlos starten →